Depression with Excessive Daytime Sleepiness?

Trouble staying awake during the day?

Every morning, thousands of people with obstructive sleep apnea (OSA) and depression wake up tired. The purpose of this research study is to determine if an FDA-approved drug for reducing daytime sleepiness in people with treated OSA is also effective in people with treated OSA and depression.

Who qualifies for this study? If you are between the ages of 18 and 65 years old, you may qualify for this study if:

You have daytime sleepiness caused by obstructive sleep apnea

You use CPAP therapy to treat your apnea

You are taking a prescription medication for depression

Patient Exclusion Criteria: Patients who have a confirmed or suspected diagnosis of a currently active sleep disorder other than Obstructive Sleep Apnea/Hypopnea.

Contact:
Patrice Harris, Research Assistant
Neurotrials Research, Inc.
1100 Johnson Ferry Road NE, Suite 420
Atlanta, GA 30342
Telephone: 404-851-9934
Fax: 404-851-9458
Email: pharris@neurotrials.com